Beta-carotene takes a collective beating

Abstract

Various studies of Beta-carotene have been halted early due to increased morbidity and mortality with Beta-carotene supplementation. These studies provide strong evidence that Beta-carotene has no benefit against heart disease or cancer, as well as possible evidence that it can cause harm in high-risk individuals.